Mortality Among Children Under Five Years of Age Living With HIV on Antiretroviral Treatment From HIV Case Surveillance Data, Malawi, 2022.

IF 2.9 4区医学 Q3 IMMUNOLOGY

Pediatric Infectious Disease Journal Pub Date : 2024-08-05 DOI:10.1097/INF.0000000000004491

Kelly S Chapman, Misheck Luhanga, George Mtonga, Nickolas Agathis, Dumbani Kayira, Susan Hrapcak, Monita Patel, Howard Kress, Melissa Arons

引用次数: 0

Abstract

From Malawi's HIV case surveillance, we report clinical characteristics and outcomes of 4461 children living with HIV on antiretroviral treatment aged <5 years from January to December, 2022. Among the 4% of children living with HIV who died, 43% were asymptomatic, 35% had advanced or severe symptoms at the time of HIV diagnosis and 50% died within 6 months of receiving an HIV diagnosis.

查看原文本刊更多论文

从 2022 年马拉维 HIV 病例监测数据看接受抗逆转录病毒治疗的五岁以下 HIV 感染儿童的死亡率。

我们从马拉维的艾滋病毒病例监测中，报告了 4461 名接受抗逆转录病毒治疗的艾滋病毒感染儿童的临床特征和治疗结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Infectious Disease Journal 医学-传染病学

CiteScore

6.30

自引率

2.80%

发文量

566

审稿时长

2-4 weeks

期刊介绍： The Pediatric Infectious Disease Journal® (PIDJ) is a complete, up-to-the-minute resource on infectious diseases in children. Through a mix of original studies, informative review articles, and unique case reports, PIDJ delivers the latest insights on combating disease in children — from state-of-the-art diagnostic techniques to the most effective drug therapies and other treatment protocols. It is a resource that can improve patient care and stimulate your personal research.

文献相关原料

公司名称	产品信息	采购帮参考价格